Mfn2 could attenuate mitochondrial damage, cellular oxidative stress, and apoptosis in the animal models of cerebral ischemia-reperfusion (IR) injury and Alzheimer disease [62–64]. The gene discussed is MFN2; the disease is early-onset autosomal dominant Alzheimer disease.